Home NDC 64980-333-14 TEMOZOLOMIDE
Product NDC 64980-333
Requested package NDC 64980-333-14
11-digit product format 649800333
Labeler code 64980
Product ID 64980-333_1c22f9d0-ae27-4e69-8b33-e634071128e8
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name temozolomide
Dosage form CAPSULE
Route ORAL
Labeler Rising Pharmaceuticals, Inc.
Application ANDA206309
Marketing category ANDA
Marketing start 2017-03-17
Marketing end 0000-00-00
Substance TEMOZOLOMIDE
Active strength 5 mg/1
Pharmacologic classes Alkylating Activity [MoA],Alkylating Drug [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206309-001 TEMOZOLOMIDE TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 A206309-002 TEMOZOLOMIDE TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 A206309-003 TEMOZOLOMIDE TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 A206309-004 TEMOZOLOMIDE TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 A206309-005 TEMOZOLOMIDE TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 A206309-006 TEMOZOLOMIDE TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 252 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206309-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A206309-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206309-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206309-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206309-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206309-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206309-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206309-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206309-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206309-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206309-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206309-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-04-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206309-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL AB 2016-04-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206309-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL AB 2016-04-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206309-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-04-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206309-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-04-27 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 252 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 64980-333-14 64980033314 14 CAPSULE in 1 BOTTLE, PLASTIC (64980-333-14) 14 capsule 2017-03-17 0000-00-00 No No Current